Fairmount Funds Management LLC 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-01 5:42 pm Sale | 2024-03-28 | 13D | Apogee Therapeutics, Inc. APGE | Fairmount Funds Management LLC | 4,762,558 9.990% | -640,495 (-11.85%) | Filing |
| 2024-01-31 4:30 pm Purchase | 2024-01-29 | 13D | Apogee Therapeutics, Inc. APGE | Fairmount Funds Management LLC | 5,403,053 9.990% | 1,496,851 (+38.32%) | Filing |
| 2023-07-21 4:31 pm Purchase | 2023-07-13 | 13D | Apogee Therapeutics, Inc. APGE | Fairmount Funds Management LLC | 3,906,202 9.990% | 3,906,202 (New Position) | Filing |